Key result
2-pyrocatechuic acid dose-dependently attenuates carboplatin-induced hematological toxicity in rats.
Why the study?
Hematological toxicity caused by carboplatin chemotherapy limits its clinical use, necessitating evaluation of protective agents against these adverse effects.
Does 2-pyrocatechuic acid prevent carboplatin-induced hematological toxicities in Wistar rats?
Does 2-pyrocatechuic acid prevent carboplatin-induced hematological toxicities in Wistar rats?
2-pyrocatechuic acid shows potential as a protective agent against carboplatin-induced hematological toxicities in a rat model.
Answers are grounded in this paper and cite their sources.
May reduce carboplatin hematotoxicity in rats; leaves open translation to human oncology practice.
Hematological toxicity or pancytopenia produced by carboplatin chemotherapy tends to limit the clinical usage of carboplatin as a potent antineoplastic agent. The current investigation was aimed at evaluation of the protective activity of a plant phenolic acid i.e. 2-pyrocatechuic acid (2,3 dihyroxybenzoic acid) against hematological adverse effects induced by carboplatin in Wistar rats. Intraperitoneal injection carboplatin (35 mg/kg) for 6 days resulted in significant alterations in hematological parameters such as decreased red blood cell, hemoglobin, total leukocyte and differential leukocyte counts and increased eosinophil counts in rat blood indicating severe hematological toxicities. Pre and co-administration of 2-pyrocatechuic acid at the doses 10, 30 and 100 with CP significantly attenuated the altered hematological indices in a dose-dependent manner exhibiting its efficacy as a protective agent for the amelioration and prevention of hematological toxicities induced by carboplatin chemotherapy.
No takes yet. Share an insight, caveat, or question.
Pujari et al. (2022) studied Carboplatin-induced hematological toxicities. 2-pyrocatechuic acid vs. Carboplatin alone was evaluated on Hematological parameters (red blood cell, hemoglobin, total/differential leukocyte, and eosinophil counts). Pre- and co-administration of 2-pyrocatechuic acid at doses of 10, 30, and 100 significantly attenuated carboplatin-induced hematological toxicities in Wistar rats in a dose-dependent manner.
Synapse has enriched 10 related papers. Consider them for comparative context: